Event Name  ,Peripheral Neuropathy  
Grade of Event  ,Management/Next Dose  
Grade 1-2  ,"No change in next dose. Treatment of neuropathy symptoms may be offered as available in line with local standard of care. If a participant is receiving an ART drug associated with peripheral neuropathy (PN), stopping that particular drug and switching to an alternative nucleoside reverse transcriptase inhibitor (NRTI) is recommended, where available.  "
Grade 3-4   ,Discontinue vincristine. Symptomatic treatments to treat neuropathy symptoms may be offered as available in line with local standard of care.  
